Search clinical trials for: Poly(ADP-ribose) polymerase-1 inhibitor
Total 104153 results
-
Fujun ZhangRecruitingSarcoma,Soft Tissue | Brachytherapy | Poly(ADP-ribose) Polymerase InhibitorsChina
-
Tesaro, Inc.WithdrawnLymphoma | Mantle-Cell
-
National Cancer Institute (NCI)RecruitingPancreatic Acinar Cell CarcinomaUnited States
-
Merck Sharp & Dohme LLCTerminatedNeoplasms | Solid Tumors
-
AstraZenecaCompletedOvarian Neoplasms | BRCA1 Protein | BRCA2 ProteinNetherlands, Belgium, United Kingdom, Poland
-
SanofiCompleted
-
zr Pharma & GmbHCompletedAdvanced Solid TumorsUnited Kingdom
-
The University of Hong KongRecruitingRecurrent Glioblastoma | Recurrent Glioma | Poly ADP Ribose Polymerase (PARP) Inhibitor | PTEN Gene Inactivation | IDH MutationHong Kong
-
University of Alabama at BirminghamTerminatedOvarian Cancer | Resistant BRCA Wild-Type Ovarian CancerUnited States
-
Abramson Cancer Center at Penn MedicineActive, not recruitingProstate CancerUnited States
-
Jiangsu Hansoh Pharmaceutical Co., Ltd.RecruitingBreast Cancer | Colorectal Cancer | Pancreatic Cancer | Ovarian Cancer | Prostatic CancerChina
-
AstraZenecaKuDOS Pharmaceuticals LimitedCompletedMelanoma NeoplasmsUnited States, United Kingdom
-
University of Alabama at BirminghamWithdrawnOvarian Cancer RecurrentUnited States
-
University of Alabama at BirminghamTesaro, Inc.; Susan G. Komen Breast Cancer Foundation; Translational Breast Cancer... and other collaboratorsRecruitingMetastatic Breast Cancer | HER2 Positive Breast CarcinomaUnited States
-
National Cancer Institute (NCI)RecruitingEGFR-Mutated Non-Small-Cell Lung Carcinoma | Small Cell/NeuroendocrineUnited States
-
ARCAGY/ GINECO GROUPTesaro, Inc.Completed
-
Eisai Inc.Completed
-
AstraZenecaCompletedAdvanced Ovarian Cancer | Paclitaxel | Carboplatin | Triple Negative Metastatic Breast CancerBelgium, Netherlands, United Kingdom
-
AstraZenecaKuDOS Pharmaceuticals LimitedCompleted
-
Teva Branded Pharmaceutical Products R&D, Inc.Terminated
-
Kristina LindemannUniversity Hospital of North Norway; Haukeland University Hospital; Sorlandet... and other collaboratorsCompletedOvarian Cancer | Peritoneal CancerNorway
-
Sun Yat-sen UniversityHutchmedRecruitingOvarian Cancer | Platinum-resistant Ovarian Cancer | Primary Peritoneal Cancer | Ovarian Carcinoma | Fallopian Tube CarcinosarcomaChina
-
Inotek Pharmaceuticals CorporationCompletedAcute Myocardial InfarctionUnited States, Israel
-
Zenith EpigeneticsPfizer; Newsoara Biopharma Co., Ltd.TerminatedTriple Negative Breast CancerUnited States, Belgium, China, Spain
-
Leiden University Medical CenterRadboud University Medical Center; AstraZeneca; University Medical Center Groningen and other collaboratorsActive, not recruitingUterine Neoplasms | Endometrial Neoplasms | Endometrium CancerNetherlands
-
Tesaro, Inc.RecruitingOvarian NeoplasmsSpain, United States, Canada
-
National Cancer Institute (NCI)CompletedAstrocytoma | Ependymoma | Medulloblastoma | Pontine Glioma | PNETUnited States
-
AstraZenecaKuDOS Pharmaceuticals LimitedCompletedMalignant Solid TumorsUnited Kingdom
-
Washington University School of MedicineActive, not recruiting
-
Affiliated Hospital of Jiangnan UniversityRecruitingCarcinoma, Non-Small-Cell Lung | EGF-R Positive Non-Small Cell Lung CancerChina
-
AstraZenecaParexelWithdrawnOvarian CancerUnited States, Italy, Canada, Spain
-
AstraZenecaCompletedNeoplasm MetastasisUnited Kingdom
-
University of California, San FranciscoGlaxoSmithKlineRecruitingMetastatic Solid Tumor | BRCA1 Mutation | BRCA2 Mutation | PALB2 Gene Mutation | ATM Gene MutationUnited States
-
Tesaro, Inc.Completed
-
AbbVieCompletedSmall Cell Lung CancerUnited States, Australia, Belgium, Canada, Czechia, France, Hungary, Korea, Republic of, Netherlands, Romania, Russian Federation, Spain
-
Lei LiRecruitingEpithelial Ovarian Cancer | Homologous Recombination Deficiency | Homologous Recombination Repair Gene Mutation | Drug Resistance | Overall Survival | Progression-free Survival | Poly(ADP-ribose) Polymerase InhibitorChina
-
Sarah E TaylorAmerican Society of Clinical OncologyTerminatedOvarian CancerUnited States
-
Hospices Civils de LyonNot yet recruitingAdvanced Malignant Pleural or Peritoneal Mesothelioma
-
AstraZenecaCompletedAdvanced Solid TumorsUnited States, Spain
-
Eisai Inc.TerminatedUnresectable Stage III Melanoma | Wild Type BRAF Stage IV MelanomaUnited States
-
Hebei Medical University Fourth HospitalNot yet recruiting
-
Seoul National University HospitalSamsung Medical Center; Takeda; Asan Medical Center; Yonsei UniversityNot yet recruitingOvarian Cancer | Epithelial Ovarian Cancer | Ovarian Cancer Stage IV | Ovarian Cancer Stage III
-
AstraZenecaEnrolling by invitationBreast Cancer | Ovarian CancerItaly, Spain, United States, Canada, Belgium, Denmark, Korea, Republic of, Czechia, Turkey, China, United Kingdom, Taiwan, Brazil, Israel, France, Hungary, Poland, Portugal, Germany, Russian Federation, Bulgaria, Finland, Slovenia, Sw...
-
Zhejiang Cancer HospitalActive, not recruitingEpithelial Ovarian CancerChina
-
Jiangsu HengRui Medicine Co., Ltd.Completed
-
ARCAGY/ GINECO GROUPAstraZenecaCompletedRelapsed Ovarian Cancers PatientsFrance
-
Royal Marsden NHS Foundation TrustAstraZenecaUnknownGastric Cancer | Oesophageal Cancer | Gastro-Oesophageal Junction CancerUnited Kingdom
-
Tesaro, Inc.Approved for marketingRecurrent Ovarian Cancer
-
Vejle HospitalAbbottCompletedRecurrent, Epithelial Ovarian CancerDenmark
-
AstraZenecaCompletedOvarian NeoplasmsSpain, United States, Belgium, United Kingdom, Israel, Poland, Germany, Sweden, Australia